The FDA has classified three drug recalls as Class II actions in enforcement reports released July 8, affecting injectable medications distributed in the U.S. Here are the recalled drugs:
Pharmacy
Healthcare is built on trust. Patients trust that coverage decisions are made in their best interest. Employers trust that benefit strategies are designed to control cost and improve outcomes. Hospitals and health systems trust that reimbursement and access decisions are…
Hyde Park, Ill.-based University of Chicago Medicine’s Harvey, Ill.-based Ingalls Memorial Hospital pharmacy department has become the latest addition to UChicago Medicine’s American Society of Health-System Pharmacists Certified Center of Excellence designation, according to a July 3 LinkedIn post from…
Houston Methodist Cypress Hospital has named Amanda Beck, PharmD, to director of hospital operations and pharmacy after 11 years with Houston Methodist. In her new role, Dr. Beck will work with the hospital’s COO to oversee performance excellence, facilities, environmental…
Pharmacy is a highly litigated corner of healthcare, with major fights running on four separate tracks: state laws banning PBMs from owning pharmacies, drugmakers challenging state 340B protections, PBMs facing antitrust claims over reimbursement practices and fraud enforcement actions tied…
Advertisement
In 2026, insurers have been taking steps to hone their specialty pharmacy approaches. Some health insurers are expanding their offerings and venturing into healthcare services. Others are seeking strategies to tackle cost pressures, as prescription drug spend has been a…
Nearly 5,000 independent pharmacies have filed a federal lawsuit against Prime Therapeutics, alleging the pharmacy benefit manager conspired with Express Scripts to suppress pharmacy reimbursement rates and increase fees in violation of federal antitrust law. The complaint was filed July…
Health systems are pouring capital into specialty pharmacy, community pharmacy and infusion capacity, betting that owning the pharmacy touchpoint is now a strategic necessity, not a side business. Here are four notes on where that investment is headed: 1. Specialty…
A federal judge has temporarily blocked Colorado’s first-in-the-nation prescription drug price cap, preventing a cap on Amgen’s Enbrel from taking effect while the company’s lawsuit against the state proceeds. U.S. District Judge Daniel Domenico ruled Amgen is substantially likely to…
The FDA has been busy over the past month, from expanding a gene therapy to younger patients to weighing whether “wellness” peptides belong on pharmacy compounding lists. Here are four things to know: 1. The FDA reshuffled its peptide advisory…